在长期脱极化期间,亚量子释放在上腺色氨酸细胞中并不占主导地位
Lisi Wei1, Xin Wang1, Min Sun1
1National Institute of Neurological Disorders and Stroke, 35 Convent Dr., Bldg. 35, Bethesda, MD 20892, USA.
Biophysical reports
|May 9, 2025
概括
这项研究挑战了上腺氨酸细胞中亚量子释放假说. 结果表明,在刺激过程中,部分发射器释放并不普遍,这质疑了融合孔闭合的占主导地位.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 外细胞体对像突触传播和应激反应这样的功能至关重要.
- "一切或没有"量子假设表明,囊泡内容完全释放.
- 亚量子释放或部分发射器释放被认为是主要的机制,特别是在氨酸细胞中.
研究的目的:
- 为了研究上腺胺细胞中亚量子释放的流行情况.
- 为了测试这种预测,即聚变孔封闭 (接吻和逃跑聚变) 是主导的,并且阻止它会增加量子尺寸.
- 为了确定亚量子释放是否是高刺激期间的重要机制.
主要方法:
- 同时对融合孔闭合的成像和对甲醇胺释放的电压计记录.
- 通过高的应用来刺激克罗马芬细胞.
- 分析不同整合时间的电流电荷和阻断聚孔闭合的分析.
主要成果:
- 发现融合孔封闭并不是主要的释放机制.
- 当使用足够的整合时间时,抑制聚变孔封闭并没有导致量子尺寸的增加.
- 这些结果与亚量子释放假设的预测相矛盾.
结论:
- 在上腺胺细胞中高刺激期间,亚量子释放并不普遍.
- 在这些条件下",一切或没有"量子释放机制似乎占主导地位.
- 聚变孔封闭在 катехо胺释放中的作用需要进一步研究.
相关概念视频
Adrenergic Neurons: Neurotransmission
3.5K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.5K
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K


